BenzingaOctober 26, 2026 at 3:15 AM NYYesterday
Regeneron Pharma Extends Agreement With BARDA, Part Of ASPR Within US Department Of HHS, To Provide Additional Supply Of Inmazeb For US Preparedness Against Ebola Disease
Updated agreement expands 2020 procurement agreement with BARDA for Regeneron's first-in-class antibody treatment for Orthoebolavirus zairense, adding value of approximately $270 millionTARRYTOWN, N.Y., Oct. 26,
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
